🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, open label, multicentre phase II trial followed by phase III co...
Status
Completed
Location
CRLC Val d'Aurelle
Start Date
2004-04
Trial ID
NCT00208260
Treatments Being Tested
The aim of this adaptive Phase 3 trial is to show a statistically significa...
Status
Completed
Location
Compassionate Cancer Care Medical Group, Inc
Start Date
2018-10-16
Trial ID
NCT03126435
Treatments Being Tested
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This is a randomized multicentre phase II trial with a large translational ...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2020-10-14
Trial ID
NCT04469556
Treatments Being Tested
This study aims to evaluate the safety and efficacy of Ivonescimab, a bispe...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2025-02-08
Trial ID
NCT06844422
Treatments Being Tested
Laboratory studies suggest that the study drug may stop cancer cells from g...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2013-04
Trial ID
NCT01764477
Treatments Being Tested
The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients ...
Status
Active Not Recruiting
Location
Jeroen Bosch Hospital
Start Date
2021-09-07
Trial ID
NCT04927780
Treatments Being Tested
In this Phase II study a dose of 2.8 mg (eight 0.35 mg siG12D-LODERs) will ...
Status
Unknown
Location
Hackensack Meridian Health
Start Date
2018-03-07
Trial ID
NCT01676259
Treatments Being Tested
In this prospective study, new diagnostic tools will be explored for patien...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2022-12-12
Trial ID
NCT05298722
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested